Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...